Upside Biotechnologies raises Series A funds to advance skin replacement therapy for burns March 22, 2017
Metriopharm reports topline results from phase IIa study of MP-1032 in plaque psoriasis March 15, 2017
Galectin Therapeutics reports promising results for GR-MD-02 in severe refractory atopic dermatitis March 15, 2017
Replicel completes phase I study of autologous cell therapy RCH-01 for androgenetic alopecia March 15, 2017
Fixed-dose combination of oxybutynin and pilocarpine is effective in treating hyperhidrosis March 7, 2017
RSS